Ayón Chang, C., Castán, D., Mora Carmona, A., Naranjo, D., Obando, F., & Mora Román, J. J. (2022). Monoclonal antibodies: A therapeutic option for the treatment of ophthalmic diseases of the eye posterior segment.
Chicago Style CitationAyón Chang, Catalina, Daniel Castán, Adrián Mora Carmona, Dunia Naranjo, Francini Obando, i Juan José Mora Román. Monoclonal Antibodies: A Therapeutic Option for the Treatment of Ophthalmic Diseases of the Eye Posterior Segment. 2022.
Cita MLAAyón Chang, Catalina, et al. Monoclonal Antibodies: A Therapeutic Option for the Treatment of Ophthalmic Diseases of the Eye Posterior Segment. 2022.
Atenció: Aquestes cites poden no estar 100% correctes.